Duska Therapeutics, Inc. (DSKA.OB) Completes Corporate Name Change to Cordex Pharma
1/28/2009 11:01:57 AM
More...
|
Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29
1/26/2009 11:19:58 AM
More...
|
Duska Therapeutics, Inc. (DSKA.OB) Applies for Phase 3 Special Protocol Assessment Company Nears Initiation Of Pivotal Phase 3 Clinical Trial For ATPace
11/20/2008 9:50:47 AM
More...
|
Duska Therapeutics, Inc. (DSKA.OB) Provides Program Update and Reports Third Quarter 2008 Financial Results
11/20/2008 6:04:15 AM
More...
|
Duska Therapeutics, Inc. (DSKA.OB) Sets Third Quarter 2008 Business Review and Program Update Call
11/18/2008 10:26:47 AM
More...
|
Duska Therapeutics, Inc. (DSKA.OB) and DSM Pharmaceuticals, Inc. in Manufacturing Collaboration for PSVT Drug Product Pivotal Phase 3 Clinical Trial For Duska's ATPace In Planning Stage
11/10/2008 10:00:57 AM
More...
|
Duska Therapeutics, Inc. (DSKA.OB) Acquires Technology for ATPotent Sperm Motility Program
10/30/2008 11:51:12 AM
More...
|
Leading Heart Specialist Joins Duska Therapeutics, Inc. (DSKA.OB) as Scientific Consultant
10/24/2008 8:04:05 AM
More...
|
Duska Therapeutics, Inc. (DSKA.OB) Provides Clinical Program Review and Reports Second Quarter 2008 Financial Results
8/21/2008 8:29:05 AM
More...
|
Duska Therapeutics, Inc. (DSKA.OB) Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
8/12/2008 8:51:46 AM
More...
|
|